Retinal vasculopathies: Diabetic retinopathy

Encyclopedia of the Eye, Four-Volume Set

Volumn , Issue , 2010, Pages 109-117

  Steinle, N C ^a   Ambati, J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Blindness; Clinically significant macular edema; CSME; Diabetes mellitus; Diabetic retinopathy; DM; Macular edema; Neovascularization; Nonperfusion; Nonproliferative diabetic retinopathy; NPDR; NVD; NVE; PDR; Proliferative diabetic retinopathy; Retinal detachment; Vision loss; Visual acuity loss; Vitreous hemorrhage

Indexed keywords

EID: 85058838744     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374203-2.00213-X     Document Type: Chapter

References (16)

1. L.M. Aiello Perspectives on diabetic retinopathy American Journal of Ophthalmology 136 2003 122-135.
2. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf (accessed June 2009).
3. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The New England Journal of Medicine 329 1993 977-986.
4. Diabetes Control and Complications Trial Research Group Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial Ophthalmology 102 1995 647-661.
5. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS report 8 Ophthalmology 88 1981 583-600.
6. Early Treatment Diabetic Retinopathy Study Research Group Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report 2 Ophthalmology 94 1987 761-774.
7. Early Treatment Diabetic Retinopathy Study Research Group Early photocoagulation for diabetic retinopathy. ETDRS report 9 Ophthalmology 98 1991 766-785.
8. Early Treatment Diabetic Retinopathy Study Research Group Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS Report 19 Archives of Ophthalmology 113 1995 1144-1155.
9. J.J. Kanski Clinical Ophthalmology 6th edn. 2007 Butterworth Heinemann-Elsevier Philadelphia, PA.
10. R. Klein., B.E. Klein., S.E. Moss., M.D. Davis., D.L. DeMets The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years Archives of Ophthalmology 102 1984 520-526.
11. R. Klein., B.E. Klein., S.E. Moss., M.D. Davis., D.L. DeMets The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years Archives of Ophthalmology 102 1984 527-532.
12. Preferred Practice Patters Committee Retina Panel Diabetic Retinopathy 2003 American Academy of Ophthalmology San Francisco November 2003.
13. S.J. Ryan., D.R. Hinton., A.P. Schachat., C.P. Wilkinson Retina 4th edn. 2006 Mosby-Elsevier Philadelphia, PA.
14. United Kingdom Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33 Lancet 352 1998 837-853.
15. United Kingdom Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38 British Medical Journal 317 1998 703-713.
16. http://www.uptodate.com/online/content/topic.do?topicKey=diabetes/12336&selectedTitle=1~90&source=search_result (accessed June 2009).